Publicaciones en las que colabora con Pablo Aguiar Fernández (49)

2024

  1. 18F-FDG positron emission tomography as a marker of disease activity and treatment response in ankylosing spondylitis and psoriatic arthritis

    Scientific Reports, Vol. 14, Núm. 1

  2. Biodistribution and pharmacokinetics of [89Zr]-anti-VEGF mAbs using PET in glioblastoma rat models

    International Journal of Pharmaceutics, Vol. 652

  3. Partial volume correction in longitudinal tau PET studies: is it really needed?

    NeuroImage, Vol. 289

  4. Quantitative brain [18F]FDG PET beyond normal blood glucose levels

    NeuroImage, Vol. 300

2022

  1. 18F-florbetapir PET as a marker of myelin integrity across the Alzheimer’s disease spectrum

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 49, Núm. 4, pp. 1242-1253

2021

  1. A systematic review of pet textural analysis and radiomics in cancer

    Diagnostics, Vol. 11, Núm. 2

  2. Correction to: Is FDG-PET texture analysis related to intratumor biological heterogeneity in lung cancer? (European Radiology, (2021), 31, 6, (4156-4165), 10.1007/s00330-020-07507-z)

    European Radiology

  3. Feasibility of Longitudinal Brain PET with Real-Time Arterial Input Function in Rats

    Molecular Imaging and Biology, Vol. 23, Núm. 3, pp. 350-360

  4. Is FDG-PET texture analysis related to intratumor biological heterogeneity in lung cancer?

    European Radiology, Vol. 31, Núm. 6, pp. 4156-4165

  5. SimPET—An open online platform for the Monte Carlo simulation of realistic brain PET data. Validation for 18F-FDG scans

    Medical Physics, Vol. 48, Núm. 5, pp. 2482-2493

2020

  1. -FMISO PET/MRI Imaging Shows Ischemic Tissue around Hematoma in Intracerebral Hemorrhage

    Molecular Pharmaceutics, Vol. 17, Núm. 12, pp. 4667-4675

  2. 3D printed tacrolimus rectal formulations ameliorate colitis in an experimental animal model of inflammatory bowel disease

    Biomedicines, Vol. 8, Núm. 12, pp. 1-19

  3. Intensity normalization methods in brain FDG-PET quantification

    NeuroImage, Vol. 222

  4. PET study of ocular and blood pharmacokinetics of intravitreal bevacizumab and aflibercept in rats

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 154, pp. 330-337

  5. Prolonged Migraine Stuttering Aura: Structural, Functional, and Video Neuroimaging Study of an Atypical Migraine Aura. A Case Report

    Headache, Vol. 60, Núm. 4, pp. 776-780

  6. White matter hyperintensities are associated with subthreshold amyloid accumulation

    NeuroImage, Vol. 218

2019

  1. Celia’s encephalopathy and c.974dupG in BSCL2 gene: a hidden change in a known variant

    Neurogenetics, Vol. 20, Núm. 2, pp. 73-82

  2. Evaluation of the therapeutic activity of melatonin and resveratrol in Inflammatory Bowel Disease: A longitudinal PET/CT study in an animal model

    International Journal of Pharmaceutics, Vol. 572

  3. Prediction of Alzheimer's disease dementia with MRI beyond the short-term: Implications for the design of predictive models

    NeuroImage: Clinical, Vol. 23

  4. Staging the cognitive continuum in prodromal Alzheimer's disease with episodic memory

    Neurobiology of Aging, Vol. 84, pp. 1-8